Results 31 to 40 of about 32,260 (226)

Cardiovascular Risk Assessement in Osteoporotic Patients Using Osteoprotegerin as a Reliable Predictive Biochemical Marker

Ibn Al-Haitham Journal for Pure and Applied Sciences, 2018
       Some studies indicated a relationship between increased serum levels of osteoprotegerin with arterial calcification and as a result, it leads to the risk of cardiovascular disease.
Noora Wael Rasheed, Ooroba Jameel Taresh
doaj   +1 more source

Osteoprotegerin reduces osteoclast resorption activity without affecting osteogenesis on nanoparticulate mineralized collagen scaffolds

Science Advances, 2019
Osteoprotegerin reduces osteoclast resorption activity without affecting osteogenesis on nanoparticulate mineralized collagen. The instructive capabilities of extracellular matrix–inspired materials for osteoprogenitor differentiation have sparked ...
Xiaoyan Ren, Qi Zhou, D. Foulad, Aleczandria S. Tiffany, Marley J. Dewey, D. Bischoff, T. Miller, R. Reid, T. He, D. Yamaguchi, B. Harley, Justine C. Lee   +11 more
semanticscholar   +1 more source

Vitamin D 3, osteoprotegerin and other hormonal and metabolic parameters in female patients with type 2 diabetes

Ожирение и метаболизм, 2012
The article presents the results of evaluation of vitamin D3, osteoprotegerin, carbohydrate and fat metabolic parameters in women with type 2 diabetes and obesity.

doaj   +1 more source

The role of osteoprotegerin in the development, progression and management of abdominal aortic aneurysms

Open Medicine, 2020
Osteoprotegerin (OPG) appears to be a very promising marker both in the diagnosis of abdominal aortic aneurysms (AAAs) and as a potential target in its treatment.
Migacz Maciej, Janoska-Gawrońska Agata, Holecki Michał, Chudek Jerzy   +3 more
doaj   +1 more source

Osteoprotegerin is a new marker of cardiovascular diseases [PDF]

Терапевтический архив, 2017
Osteoprotegerin (OPG) is a glycoprotein that is a representative of the tumor necrosis factor-α receptor superfamily. Information about the possible role of OPG in the development of cardiovascular diseases has begun to appear in the literature in recent
A F Verbovoy, I A Tsanava, E V Mitroshina, L A Sharonova   +3 more
doaj   +1 more source

The association of bone turnover markers with pro- and anti-inflammatory adipokines in patients with gestational diabetes

Annals of Agricultural and Environmental Medicine, 2015
Objective The aim of the study was to assess differences in circulating osteocalcin (OC) and osteoprotegerin (OPG), as well as in their expression in subcutaneous adipose tissue (SAT), visceral adipose tissue (VAT) and placental tissue obtained from ...
Beata Telejko, Katarzyna Kalejta, Mriusz Kuzmicki, Natalia Wawrusiewicz-Kurylonek, Danuta Lipinska, Justyna Pliszka, Juliusz Wilk, Anna Zielinska, Angelika Sobota, Jacek Szamatowicz, Adam Kretowski, Maria Gorska   +11 more
doaj   +1 more source

Suppression of AMP‐activated protein kinase reverses osteoprotegerin‐induced inhibition of osteoclast differentiation by reducing autophagy

Cell Proliferation, 2019
Osteoclasts (OC) are unique terminally differentiated cells whose primary function is bone resorption. We previously showed that osteoprotegerin (OPG) inhibits OC differentiation in vitro by enhancing autophagy via the adenosine monophosphate‐activated ...
Xishuai Tong, Chuang Zhang, Dong Wang, R. Song, Yonggang Ma, Ying Cao, Hongyan Zhao, Jianchun Bian, Jianhong Gu, Zongping Liu   +9 more
semanticscholar   +1 more source

Endogenous Calcification Inhibitors in the Prevention of Vascular Calcification: A Consensus Statement From the COST Action EuroSoftCalcNet

Frontiers in Cardiovascular Medicine, 2019
The physicochemical deposition of calcium-phosphate in the arterial wall is prevented by calcification inhibitors. Studies in cohorts of patients with rare genetic diseases have shed light on the consequences of loss-of-function mutations for different ...
Magnus Bäck, Tamas Aranyi, M. Leonor Cancela, Miguel Carracedo, Natércia Conceição, Georges Leftheriotis, Vicky Macrae, Ludovic Martin, Yvonne Nitschke, Andreas Pasch, Daniela Quaglino, Frank Rutsch, Catherine Shanahan, Victor Sorribas, Flora Szeri, Flora Szeri, Pedro Valdivielso, Olivier Vanakker, Hervé Kempf   +18 more
doaj   +1 more source

Comparative Study of the Cytokine Profiles of Serum and Tissues from Patients with the Ossification of the Posterior Longitudinal Ligament

Biomedicines, 2023
Background: The ossification of the posterior longitudinal ligament (OPLL) is one of the contributing factors leading to severe cervical spondylotic myelopathy (CSM). The mechanism causing ossification is still unclear.
Li-Yu Fay, Chao-Hung Kuo, Hsuan-Kan Chang, Mei-Yin Yeh, Chih-Chang Chang, Chin-Chu Ko, Tsung-Hsi Tu, Yi-Hsuan Kuo, Wang-Yu Hsu, Chien-Hui Hung, Ching-Jung Chen, Jau-Ching Wu, May-Jywan Tsai, Wen-Cheng Huang, Henrich Cheng, Meng-Jen Lee   +15 more
doaj   +1 more source

A therapeutic antibody targeting osteoprotegerin attenuates severe experimental pulmonary arterial hypertension

Nature Communications, 2019
Pulmonary arterial hypertension (PAH) is a rare but fatal disease. Current treatments increase life expectancy but have limited impact on the progressive pulmonary vascular remodelling that drives PAH.
N. Arnold, J. Pickworth, L. West, Sarah Dawson, J. Carvalho, H. Casbolt, A. Braithwaite, J. Iremonger, L. Renshall, V. Germaschewski, M. Mccourt, P. Bland-Ward, Hager Kowash, A. Hameed, A. Rothman, M. Frid, A. A. R. Thompson, H. Evans, M. Southwood, N. Morrell, D. Crossman, M. Whyte, K. Stenmark, C. Newman, D. Kiely, D. Kiely, S. Francis, A. Lawrie   +27 more
semanticscholar   +1 more source